BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition

Overview of attention for article published in Cancer Discovery, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 150 X users
patent: 3 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 250 Dimensions

Readers on

mendeley: 244 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Benzylamino substituted pyrimidopyranone derivatives, compositions, formulations and uses…

Application CN-115246841-A

China

USE OF SOS1 INHIBITORS WITH RAS INHIBITORS TO TREAT CANCERS

Application WO-2022217053-A1

World Intellectual Property Organisation (WIPO)

Bicyclic heteroaryl compounds and uses thereof

Grant US-11168102-B1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.